gynecology
Professor Jacques Ravel, from University of Maryland School of Medicine and LUCA Biologics, discusses his latest research and therapeutic innovations in the field of vaginal microbiome modulation.
By addressing biases and increasing diversity in microbiota studies, researchers can develop more accurate and inclusive health strategies for women of different backgrounds.
Certain features of the vaginal microbiota, including specific bacterial communities, could indicate an increased Chlamydia infection risk.
Understanding the vaginal microbiome is essential not only for treating gynecological conditions but also for preventing them and promoting overall well-being.
Mice born to mothers exposed to Akkermansia muciniphila during pregnancy showed improvements in stem cell activity.
The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.
A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.
A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).
Franco Vicariotto, Ospedale S. Pio X, Milan, talks about the results from a clinical trial in post-menopausal women.
The findings of a recent study suggest that the gut microbiota of women with PCOS and dyslipidemia differs from that of women with PCOS only and healthy women.
